Bioqube Ventures N.V.

https://www.bioqubeventures.com

LinkedIn: https://www.linkedin.com/company/bioqubeventures

Bioqube Ventures NV is a specialist life sciences investment firm with Managing Partners Debora Dumont, Dirk Reyn and Nico Vandervelpen. The firm was founded by Debora Dumont and Nico Vandervelpen in 2016 and has seen its team grow to 10 people over the past years. Bioqube Ventures’ team today consists of a mix of investment managers, sector experts and serial entrepreneurs that have a proven track record in successfully building and leading companies on their growth paths. Leveraging on the team’s experience, Bioqube Ventures enables early-stage life sciences companies to maximize their full potential. Bioqube Ventures recognizes the value of industry guidance and has therefore set up strategic relationships with a selected number of industry partners with complementary skills. Bioqube Ventures NV launched Bioqube Factory Fund I in May 2020 with a clear focus on therapeutics. Through a diversified investment strategy, including de-risking projects in a “Create” stage, the Fund will exclusively invest in the most promising innovative science in Europe and will put its expertise at work to ensure its portfolio flourishes. *

	Start	2016-01-01 established
	Group	Bioqube Ventures (Group)
	Industry	venture capital
	Industry 2	BIOTECH
	Person	Dumont, Debora (Debbie) (Bioqube Ventures 201611– Managing Partner + Co-Founder before LRM)
	Person 2	Vandervelpen, Nico (LRM 201006 Investment Manager Life Sciences)

	Region	Brussels
	Country	Belgium
	Street	13 Barricadenplein
	City	1000 Brussels
	Tel	+32-499-848712
		Address record changed: 2024-01-05

Basic data	Employees	A: 1 to 10 (2020-06-10)

		* Document for »About Section«: Anavo Therapeutics B.V.. (4/22/21). "Press Release: Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators". Leiden.

		Record changed: 2024-02-12